Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation …
CH Yan, JZ Wang, DH Liu, LP Xu… - European Journal of …, 2013 - Wiley Online Library
We retrospectively compared the antileukemic effects of chemotherapy alone and
chemotherapy followed by modified donor lymphocyte infusion (DLI) in 82 patients with …
chemotherapy followed by modified donor lymphocyte infusion (DLI) in 82 patients with …
[HTML][HTML] Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective …
A Takami, S Yano, H Yokoyama, Y Kuwatsuka… - Biology of Blood and …, 2014 - Elsevier
Because the efficacy of donor lymphocyte infusion (DLI) for acute myeloid leukemia (AML)
relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains uncertain …
relapse after allogeneic hematopoietic stem cell transplantation (HSCT) remains uncertain …
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a …
Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …
Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
K Harada, S Mizuno, S Yano, A Takami, H Ishii… - Annals of …, 2022 - Springer
Although haploidentical donor lymphocyte infusion (DLI) is a valid treatment option for
relapsed acute myeloid leukemia (AML), the incidence and risk factors for graft-versus-host …
relapsed acute myeloid leukemia (AML), the incidence and risk factors for graft-versus-host …
Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell …
Y Tan, K Du, Y Luo, J Shi, L Cao, Y Zheng… - …, 2014 - Wiley Online Library
Background Donor lymphocyte infusion (DLI) was used as salvage therapy in leukemia
relapse after allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but existing …
relapse after allogeneic hematopoietic stem cell transplantation (allo‐HSCT), but existing …
Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
Leukemia relapse is a serious therapeutic challenge following hematopoietic stem cell
transplantation (HSCT). In this retrospective study, 23 patients [15 (65.2%) AML, eight …
transplantation (HSCT). In this retrospective study, 23 patients [15 (65.2%) AML, eight …
[HTML][HTML] Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus-host disease–guided multiple DLIs could improve …
CH Yan, Q Liu, D Wu, X Zhang, LP Xu, X Zhang… - Biology of Blood and …, 2017 - Elsevier
Patients with refractory/relapsed acute leukemia who have received allogeneic
hematopoietic stem cell transplantation (allo-HSCT) are still at a high risk for relapse post …
hematopoietic stem cell transplantation (allo-HSCT) are still at a high risk for relapse post …
Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte …
SJ Choi, JH Lee, S Kim, YS Lee, M Seol… - Bone marrow …, 2005 - nature.com
Donor leukocyte infusion (DLI) alone has very limited efficacy for patients with acute
lymphoblastic leukemia (ALL) who have relapsed after allogeneic bone marrow …
lymphoblastic leukemia (ALL) who have relapsed after allogeneic bone marrow …
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
C Schmid, M Labopin, N Schaap, H Veelken… - Bone marrow …, 2022 - nature.com
We report on 318 patients with acute leukemia, receiving donor lymphocyte infusion (DLI) in
complete hematologic remission (CHR) after allogeneic stem cell transplantation (alloSCT) …
complete hematologic remission (CHR) after allogeneic stem cell transplantation (alloSCT) …
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patients
W Sun, XD Mo, XH Zhang, LP Xu, Y Wang… - Bone Marrow …, 2019 - nature.com
This study investigated the prognostic factors in patients (n= 89) who experienced relapse
and received chemotherapy plus donor leukocyte infusion (Chemo-DLI) after haploidentical …
and received chemotherapy plus donor leukocyte infusion (Chemo-DLI) after haploidentical …